{{Rsnum
|rsid=3807031
|Gene=PPP1R11
|Chromosome=6
|position=30066107
|Orientation=plus
|GMAF=0.1905
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=PPP1R11
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 6.2 | 47.8 | 46.0
| HCB | 5.1 | 38.0 | 56.9
| JPT | 0.9 | 24.8 | 74.3
| YRI | 1.4 | 12.9 | 85.7
| ASW | 0.0 | 28.1 | 71.9
| CHB | 5.1 | 38.0 | 56.9
| CHD | 4.6 | 43.5 | 51.9
| GIH | 0.0 | 19.8 | 80.2
| LWK | 1.8 | 29.1 | 69.1
| MEX | 1.7 | 29.3 | 69.0
| MKK | 0.0 | 13.5 | 86.5
| TSI | 1.0 | 21.6 | 77.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3807031
|Name_s=
|Gene_s=PPP1R11, ZNRD1
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363818
}}

{{PMID Auto
|PMID=19010793
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3807031
|overall_frequency_n=18
|overall_frequency_d=128
|overall_frequency=0.140625
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}